Cargando…

Identification of ovarian high-grade serous carcinoma cell lines that show estrogen-sensitive growth as xenografts in immunocompromised mice

Ovarian cancer remains a significant challenge in women worldwide. Tumors of the high-grade serous carcinoma (HGSC) type represent the most common form of the disease. Development of new therapies for HGSC has been hampered by a paucity of preclinical models in which new drugs could be tested for ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Haven Brandon, Alexis, Box, Gary, Hallsworth, Albert, Court, William, Matthews, Nicoll, Herodek, Balint, Arteagabeitia, Aitor Bermejo, Valenti, Melanie, Kirkin, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329846/ https://www.ncbi.nlm.nih.gov/pubmed/32612269 http://dx.doi.org/10.1038/s41598-020-67533-1

Ejemplares similares

Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours
por: Beloueche-Babari, M, et al.
Publicado: (2015)

Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma
por: Sriskandarajah, Priya, et al.
Publicado: (2020)

Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
por: Wagner, Steve, et al.
Publicado: (2018)

Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
por: Wagner, Steve, et al.
Publicado: (2019)

Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models
por: Okada, Seiji, et al.
Publicado: (2019)

Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma
por: Dong, Ruifen, et al.
Publicado: (2016)

FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas
por: Milton, Christopher I., et al.
Publicado: (2021)

Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model
por: McCann, Christopher K., et al.
Publicado: (2011)

Estrogen Aggravates Tumor Growth in a Diffuse Gastric Cancer Xenograft Model
por: Lee, Sunyi, et al.
Publicado: (2021)

The tipping point: Tamoxifen toxicity, central serous chorioretinopathy, and the role of estrogen and its receptors
por: Koulisis, Nicole, et al.
Publicado: (2016)

Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro
por: Burmi, Rajpal S., et al.
Publicado: (2022)

Eribulin shows high concentration and long retention in xenograft tumor tissues
por: Sugawara, Michiko, et al.
Publicado: (2017)

Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma
por: Poon, Evon, et al.
Publicado: (2020)

Identification of Multiple Novel Protein Biomarkers Shed by Human Serous Ovarian Tumors into the Blood of Immunocompromised Mice and Verified in Patient Sera
por: Beer, Lynn A., et al.
Publicado: (2013)

Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry
por: van der Ploeg, Phyllis, et al.
Publicado: (2021)

Combining TRAIL with PI3 Kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling
por: Saturno, Grazia, et al.
Publicado: (2013)

Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer
por: Shen, Yen Ting, et al.
Publicado: (2019)

CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
por: Kleinmanns, Katrin, et al.
Publicado: (2020)

On Encysted Serous Pelvic Effusions Following Puerperal Inflammation
por: Duncan, J. Matthews
Publicado: (1866)

Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure
por: Konings, Gonda FJ, et al.
Publicado: (2018)

Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research
por: Cybula, Magdalena, et al.
Publicado: (2021)

Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report
por: Najjar, Omar, et al.
Publicado: (2020)

Differential expression of estrogen receptor subtypes in ovarian high‐grade serous carcinoma and clear cell carcinoma
por: Osaku, Daiken, et al.
Publicado: (2021)

Dietary Estrogens Act through Estrogen Receptor-Mediated Processes and Show No Antiestrogenicity in Cultured Breast Cancer Cells.
por: Makela, S, et al.
Publicado: (1994)

Retroperitoneal Necrotizing Fasciitis from Fournier's Gangrene in an Immunocompromised Patient
por: Weimer, Samuel B., et al.
Publicado: (2017)

Infections in the Immunocompromised
por: Cant, Andrew, et al.
Publicado: (2009)

Immunocompromised Patients
por: Humphreys, Hilary, et al.
Publicado: (2012)

Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.
por: Modjtahedi, H., et al.
Publicado: (1993)

Disseminated Histoplasmosis: A Rare Cause of Pancytopenia in an Immunocompromised Patient
por: Avva, Kalyani, et al.
Publicado: (2022)

Discovery of 3-Alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as Selective, Orally Bioavailable CHK1 Inhibitors
por: Lainchbury, Michael, et al.
Publicado: (2012)

Inhibition of Lipoxygenases Showed No Benefit for the Musculoskeletal System in Estrogen Deficient Rats
por: Saul, Dominik, et al.
Publicado: (2021)

Developmental Exposure to Estrogen Alters Differentiation and Epigenetic Programming in a Human Fetal Prostate Xenograft Model
por: Saffarini, Camelia M., et al.
Publicado: (2015)

Evaluation of the Response of Intracranial Xenografts to VEGF Signaling Inhibition Using Multiparametric MRI
por: Boult, Jessica K.R., et al.
Publicado: (2017)

Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers
por: Ciucci, Alessandra, et al.
Publicado: (2016)

Metabolism of Estrogens: Turnover Differs between Platinum-Sensitive and -Resistant High-Grade Serous Ovarian Cancer Cells
por: Poschner, Stefan, et al.
Publicado: (2020)

KRAS‐Mutated, Estrogen Receptor‐Positive Low‐Grade Serous Ovarian Cancer: Unraveling an Exceptional Response Mystery
por: Kato, Shumei, et al.
Publicado: (2021)

Therapeutic Dose Response of Acoustic Cluster Therapy in Combination With Irinotecan for the Treatment of Human Colon Cancer in Mice
por: Bush, Nigel, et al.
Publicado: (2019)

Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1
por: Sflomos, George, et al.
Publicado: (2021)

History of the Selective Autophagy Research: How Did It Begin and Where Does It Stand Today?
por: Kirkin, Vladimir
Publicado: (2020)

Global Conservation of Protein Status between Cell Lines and Xenografts()
por: Biau, Julian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sv1n6ho4eshv5umjl3pvt0vk68